A Study of Single Ascending Doses of STAR-101 in Healthy Participants
NCT04081597 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2020-02-13
Summary
The study will include a single ascending dose approach to evaluate the safety, tolerability, and pharmacokinetic properties of STAR-101 after a single oral administration in healthy participants
Conditions
- Healthy Volunteers
Interventions
- DRUG
-
Star-101
Administered orally
- DRUG
-
Administered orally
Sponsors & Collaborators
-
Acanthas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Acanthas Pharma · Acanthas Pharma
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-02-29
- Primary Completion
- 2020-03-31
- Completion
- 2020-03-31
More Related Trials
-
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Healthy Volunteers
NCT02596399 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects
NCT03869320 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics Study Assessing Ascending Single Oral JTK-853 Doses in Healthy Subjects
NCT01475981 ·Status: COMPLETED ·Phase: PHASE1
-
An Ascending Multiple Dose Study of CD101 IV in Healthy Subjects
NCT02551549 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of XEN-101
NCT05667129 ·Status: COMPLETED ·Phase: PHASE1
-
Single Ascending Dose Study to Evaluate Pharmacokinetics and Food-Effect in Healthy Volunteers
NCT02853643 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K
NCT01387087 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Ascending Dose Study for LCB01-0371
NCT01842516 ·Status: COMPLETED ·Phase: PHASE1
-
AZD8075 Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses of AZD8075 in Healthy Male Volunteers
NCT00829127 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study in Healthy Volunteers to Assess the Tolerability and Blood Levels of a Single Dose of AZD7687
NCT01046357 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Pharmacokinetics Study of ZB004 in Healthy Participants
NCT05794516 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male Subjects
NCT03641573 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017
NCT00791752 ·Status: COMPLETED ·Phase: PHASE1
-
AZD8529 Single Ascending Dose Study
NCT00755378 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Dose of GV101 in Healthy Subjects
NCT05068947 ·Status: COMPLETED ·Phase: PHASE1
-
A Combined Single and Multiple Ascending Dose Study of ASP6858 in Healthy Subjects
NCT02359032 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of INS1007 in Healthy Japanese and Caucasian Participants
NCT05927597 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Administration of HS-10356 in Healthy Volunteers
NCT04652297 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of STAR-0310 in Healthy Adult Participants
NCT06782477 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Phase 1 Single Ascending Dose Study With ATX101
NCT07107802 ·Status: COMPLETED ·Phase: PHASE1
-
Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Participants.
NCT02107885 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of AZD4205 in Healthy Adult Subjects
NCT03728023 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects.
NCT05656274 ·Status: COMPLETED ·Phase: PHASE1
-
AZD5985 Single Ascending Dose Study
NCT00967356 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Assess Safety and Tolerability of ASP1941 After Single and Repeated Administration in Healthy Subjects
NCT01121198 ·Status: COMPLETED ·Phase: PHASE1